(Q40182879)

18 September 2017

title

Are radiogallium-labelled DOTA-conjugated somatostatin analogues superior to those labelled with other radiometals? (English)

1 reference

18 September 2017

Antunes P

1

1 reference

18 September 2017

Ginj M

2

1 reference

18 September 2017

Zhang H

3

1 reference

18 September 2017

Waser B

4

1 reference

18 September 2017

Baum RP

5

1 reference

18 September 2017

Reubi JC

6

1 reference

18 September 2017

Maecke H

7

1 reference

18 September 2017

publication date

16 January 2007

1 reference

18 September 2017

number of pages

12

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

inferred from page(s)

published in

1 reference

18 September 2017

volume

34

1 reference

18 September 2017

issue

7

1 reference

18 September 2017

page(s)

982-993

1 reference

https://scigraph.springernature.com/pub.10.1007/s00259-006-0317-x

18 September 2017

exact match

0 references

cites work

99mTc-EDDA/HYNIC-TOC: a new 99mTc-labelled radiopharmaceutical for imaging somatostatin receptor-positive tumours: first clinical results and intra-patient comparison with 111In-labelled octreotide derivatives

1 reference

12 December 2020

Neuroendocrine tumor targeting: study of novel gallium-labeled somatostatin radiopeptides in a rat pancreatic tumor model

1 reference

12 December 2020

Tumor response and clinical benefit in neuroendocrine tumors after 7.4 GBq (90)Y-DOTATOC.

1 reference

12 December 2020

Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients

1 reference

12 December 2020

Early tumor response to Hsp90 therapy using HER2 PET: comparison with 18F-FDG PET

1 reference

12 December 2020

Proof of principle for the use of 11C-labelled peptides in tumour diagnosis with PET.

1 reference

12 December 2020

Evaluation of [99mTc/EDDA/HYNIC0]octreotide derivatives compared with [111In-DOTA0,Tyr3, Thr8]octreotide and [111In-DTPA0]octreotide: does tumor or pancreas uptake correlate with the rate of internalization?

1 reference

12 December 2020

PET imaging of somatostatin receptors: design, synthesis and preclinical evaluation of a novel 18F-labelled, carbohydrated analogue of octreotide.

1 reference

12 December 2020

Yttrium-90 and indium-111 labelling, receptor binding and biodistribution of [DOTA0,d-Phe1,Tyr3]octreotide, a promising somatostatin analogue for radionuclide therapy

1 reference

12 December 2020

Yttrium-90-labelled somatostatin-analogue for cancer treatment

1 reference

12 December 2020

Exceptional increase in somatostatin receptor expression in pancreatic neuroendocrine tumour, visualised with (68)Ga-DOTATOC PET.

1 reference

12 December 2020

The possible role of 68Ga-DOTATATE PET in malignant abdominal paraganglioma.

1 reference

12 December 2020

Evaluation of Positron Emission Tomography Imaging Using [68Ga]-DOTA-D Phe1-Tyr3-Octreotide in Comparison to [111In]-DTPAOC SPECT. First Results in Patients with Neuroendocrine Tumors

1 reference

12 December 2020

DOTA-NOC, a high-affinity ligand of somatostatin receptor subtypes 2, 3 and 5 for labelling with various radiometals

1 reference

12 December 2020

Preparation and biological evaluation of copper-64-labeled tyr3-octreotate using a cross-bridged macrocyclic chelator

1 reference

12 December 2020

Receptor-mediated radionuclide therapy with 90Y-DOTATOC in association with amino acid infusion: a phase I study

1 reference

12 December 2020

64Cu-labeled folate-conjugated shell cross-linked nanoparticles for tumor imaging and radiotherapy: synthesis, radiolabeling, and biologic evaluation

1 reference

12 December 2020

Differential beta-arrestin trafficking and endosomal sorting of somatostatin receptor subtypes

1 reference

12 December 2020

Molecular imaging with copper-64.

1 reference

12 December 2020

[99mTc]Demotate, a new 99mTc-based [Tyr3]octreotate analogue for the detection of somatostatin receptor-positive tumours: synthesis and preclinical results

1 reference

12 December 2020

Peptide receptors as molecular targets for cancer diagnosis and therapy

1 reference

12 December 2020

Internalization of sst2, sst3, and sst5 receptors: effects of somatostatin agonists and antagonists.

1 reference

12 December 2020

Overview of results of peptide receptor radionuclide therapy with 3 radiolabeled somatostatin analogs.

1 reference

12 December 2020

[177Lu-DOTA(0),Tyr3] octreotate for somatostatin receptor-targeted radionuclide therapy

1 reference

12 December 2020

213Bi-[DOTA0, Tyr3]octreotide peptide receptor radionuclide therapy of pancreatic tumors in a preclinical animal model

1 reference

12 December 2020

NODAGATOC, a new chelator-coupled somatostatin analogue labeled with [67/68Ga] and [111In] for SPECT, PET, and targeted therapeutic applications of somatostatin receptor (hsst2) expressing tumors

1 reference

12 December 2020

Imaging of neuroendocrine tumors

1 reference

12 December 2020

Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use

1 reference

12 December 2020

Carcinoid and pancreatic endocrine tumors: recent advances in molecular pathogenesis, localization, and treatment

1 reference

12 December 2020

Gallium-67/gallium-68-[DFO]-octreotide--a potential radiopharmaceutical for PET imaging of somatostatin receptor-positive tumors: synthesis and radiolabeling in vitro and preliminary in vivo studies

1 reference

12 December 2020

Preclinical evaluation of new and highly potent analogues of octreotide for predictive imaging and targeted radiotherapy.

1 reference

12 December 2020

68Ga-DOTANOC: a first compound for PET imaging with high affinity for somatostatin receptor subtypes 2 and 5.

1 reference

12 December 2020

Characterization of 68Ga-DOTA-D-Phe1-Tyr3-octreotide kinetics in patients with meningiomas.

1 reference

12 December 2020

(68)Ga-labeled peptides in tumor imaging.

1 reference

12 December 2020

Imaging the pharmacodynamics of HER2 degradation in response to Hsp90 inhibitors

1 reference

12 December 2020

PET imaging of somatostatin receptors using [68GA]DOTA-D-Phe1-Tyr3-octreotide: first results in patients with meningiomas

1 reference

12 December 2020

Quantitative assessment of SSTR2 expression in patients with non-small cell lung cancer using68Ga-DOTATOC PET and comparison with18F-FDG PET

1 reference

12 December 2020

Biokinetics and imaging with the somatostatin receptor PET radioligand (68)Ga-DOTATOC: preliminary data

1 reference

12 December 2020

Comparative in vivo stability of copper-64-labeled cross-bridged and conventional tetraazamacrocyclic complexes.

1 reference

12 December 2020

10.1007/S00259-006-0317-X

Identifiers

DOI

1 reference

18 September 2017

1 reference